Evaluating Therapeutic Activity of Galectin-1 in Sarcolemma Repair of Skeletal Muscle.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2022
Historique:
entrez: 23 3 2022
pubmed: 24 3 2022
medline: 26 3 2022
Statut: ppublish

Résumé

Galectin-1 is a small (14.5 kDa) multifunctional protein with cell-cell and cell-ECM adhesion due to interactions with the carbohydrate recognition domain (CRD). In two types of muscular dystrophies, this lectin protein has shown therapeutic properties, including positive regulation of skeletal muscle differentiation and regeneration. Both Duchenne and limb-girdle muscular dystrophy 2B (LGMD2B) are subtypes of muscular dystrophies characterized by deficient membrane repair, muscle weakness, and eventual loss of ambulation. This chapter explains confocal techniques such as laser injury, calcium imaging, and galectin-1 localization to examine the effects of galectin-1 on membrane repair in injured LGMD2B models.

Identifiants

pubmed: 35320552
doi: 10.1007/978-1-0716-2055-7_36
doi:

Substances chimiques

Galectin 1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

663-683

Informations de copyright

© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Références

Camby I, Le Mercier M, Lefranc F, Kiss R (2006) Galectin-1: a small protein with major functions. Glycobiology 16(11):137R–157R. https://doi.org/10.1093/glycob/cwl025
doi: 10.1093/glycob/cwl025 pubmed: 16840800
Vallecillo-Zúniga ML, Rathgeber MF, Poulson PD, Hayes S, Luddington JS, Gill HN, Teynor M, Kartchner BC, Valdoz J, Stowell C (2020) Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models. PLoS One 15(9):e0238441
doi: 10.1371/journal.pone.0238441
Van Ry PM, Wuebbles RD, Key M, Burkin DJJMT (2015) Galectin-1 protein therapy prevents pathology and improves muscle function in the mdx mouse model of Duchenne muscular dystrophy. Mol Ther 23(8):1285–1297
doi: 10.1038/mt.2015.105
Wuebbles RD, Cruz V, Van Ry P, Barraza-Flores P, Brewer PD, Jones P, Burkin DJ (2019) Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy. Mol Ther Methods Clin Dev 13:145–153. https://doi.org/10.1016/j.omtm.2019.01.004
doi: 10.1016/j.omtm.2019.01.004 pubmed: 30788383 pmcid: 6369265
Chandra G, Defour A, Mamchoui K, Pandey K, Mishra S, Mouly V, Sreetama S, Ahmad MM, Mahjneh I, Morizono H (2019) Dysregulated calcium homeostasis prevents plasma membrane repair in Anoctamin 5/TMEM16E-deficient patient muscle cells. Cell Death Dis 5(1):1–15
Cheng X, Zhang X, Yu L, Xu H (2015) Calcium signaling in membrane repair. In: Seminars in cell and developmental biology. Elsevier, pp 24–31
Demonbreun AR, Quattrocelli M, Barefield DY, Allen MV, Swanson KE, McNally EM (2016) An actin-dependent annexin complex mediates plasma membrane repair in muscle. J Cell Biol 213(6):705–718
doi: 10.1083/jcb.201512022
Morgan J, Beauchamp J, Pagel C, Peckham M, Ataliotis P, Jat P, Noble M, Farmer K, Partridge T (1994) Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. Dev Biol 162(2):486–498
doi: 10.1006/dbio.1994.1103
Jat PS, Noble MD, Ataliotis P, Tanaka Y, Yannoutsos N, Larsen L, Kioussis D (1991) Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci 88(12):5096–5100
doi: 10.1073/pnas.88.12.5096
Carmeille R, Croissant C, Bouvet F, Bouter A (2017) Membrane repair assay for human skeletal muscle cells. In: Skeletal muscle development. Springer, pp 195–207
doi: 10.1007/978-1-4939-7283-8_14
Stowell SR, Dias-Baruffi M, Penttilä L, Renkonen O, Nyame AK, Cummings RD (2004) Human galectin-1 recognition of poly-N-acetyllactosamine and chimeric polysaccharides. Glycobiology 14(2):157–167
doi: 10.1093/glycob/cwh018
Demonbreun AR, McNally EM (2015) DNA electroporation, isolation and imaging of myofibers. J Vis Exp (106):e53551
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9(7):676
doi: 10.1038/nmeth.2019

Auteurs

Mary L Vallecillo-Zúniga (ML)

Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.

Matthew Rathgeber (M)

Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.

Daniel Poulson (D)

Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.

Braden Kartchner (B)

Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.

Jacob Luddington (J)

Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.

Hailie Gill (H)

Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.

Spencer Hayes (S)

Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.

Matthew Teynor (M)

Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.

Caleb S Stowell (CS)

Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.

Connie M Arthur (CM)

Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Harvard Glycomics Center, Harvard Medical School, Boston, MA, USA.

Sean R Stowell (SR)

Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Harvard Glycomics Center, Harvard Medical School, Boston, MA, USA.

Pam M Van Ry (PM)

Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA. pvanry@chem.byu.edu.
Department of Biochemistry, Brigham Young University, Provo, UT, USA. pvanry@chem.byu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH